 |
BioWorld-Insight-2010-05-31
Made-in-Japan Phase III Data: Enough for Pirfenidone's Win?
Biotech - Big Pharma Collaborations: Modified And Terminated Agreements, April 1 - May 27, 2010
No Abstract
Financing Finesse: Lessons Learned in Tricky VC World
NAPA, Calif. - Tucked amid vineyards at a resort far enough from town that attendees must either drive or take a shuttle for a selection of restaurants, C21 BioVentures accomplishes what it intends: To conduct a small, intense partnering conference that's cozy to the point of isolated.